All Pathways
Emergency MedicineEmergency

Acetaminophen Toxicity Management (JAMA 2023)

Acetaminophen Toxicity Management (JAMA 2023): START: Suspected Acetaminophen Toxicity → Obtain History → Initial Labs → Type of Ingestion? → Acute Sing...

Pathway Overview

14 steps

Algorithm Steps

14 total

  1. 01Start

    START: Suspected Acetaminophen Toxicity

    History of APAP ingestion or elevated level

  2. 02Action

    Obtain History

    Key information

    • Amount ingested (mg/kg)
    • Time of ingestion (critical for nomogram)
    • Single vs multiple doses
    • Immediate-release vs extended-release
    • Co-ingestants
    • Suicidal intent
  3. 03Action

    Initial Labs

    Draw at presentation

    • Serum acetaminophen level
    • LFTs (AST, ALT)
    • PT/INR
    • BMP (Cr, glucose)
    • Lactate if severe
    • Repeat APAP level at 4 hours post-ingestion
  4. 04Decision

    Type of Ingestion?

    Determines treatment approach

  5. 05Action

    Acute Single Ingestion

    Known time, single dose

    • Use Rumack-Matthew nomogram
    • APAP level at 4 hours post-ingestion (or ASAP if >4h)
    • Plot level on nomogram
    • Above treatment line → NAC indicated
  6. 06Action

    GI Decontamination

    If early presentation

    • Activated charcoal 1g/kg (max 50g)
    • Most effective within 1-2 hours of ingestion
    • Consider up to 4 hours for large ingestions
    • Contraindicated if altered mental status, aspiration risk
  7. 07Decision

    NAC Treatment Indicated?

    Based on level/nomogram or clinical

    • TREAT IF: Level above treatment line, Elevated transaminases with APAP detected, Unknown time but high risk, Massive ingestion (>150 mg/kg)
  8. 08Action

    IV NAC Protocol (21-hour)

    Standard 3-bag regimen

    • Loading: 150 mg/kg IV over 1 hour
    • Bag 2: 50 mg/kg IV over 4 hours
    • Bag 3: 100 mg/kg IV over 16 hours
    • Total: 300 mg/kg over 21 hours
    • Anaphylactoid reactions: slow infusion, antihistamines
  9. 09Action

    Monitoring During Treatment

    Assess for hepatotoxicity

    • LFTs q6-12 hours
    • PT/INR
    • Serum creatinine
    • APAP level until undetectable
    • Glucose (hypoglycemia in liver failure)
  10. 10Decision

    Continue NAC?

    Criteria for stopping

    • STOP NAC IF: APAP undetectable, INR <2, AST/ALT declining or normal
    • CONTINUE NAC IF: INR >2, AST >1000, clinical hepatotoxicity
  11. 11Warning

    Acute Liver Failure

    Transfer to liver transplant center

    • King's College Criteria for transplant:
    • - pH <7.3 after resuscitation, OR
    • - PT >100 sec (INR >6.5) + Cr >3.4 + Grade III/IV encephalopathy
    • Continue NAC (reduces mortality even in ALF)
    • Early hepatology/transplant consult
  12. 12Outcome

    Recovery/Discharge

    Hepatotoxicity resolved

    • LFTs normalizing
    • APAP undetectable
    • INR normal
    • Psychiatric evaluation if intentional
    • Safe medication storage counseling
  13. 13Action

    Oral NAC (72-hour)

    Alternative if IV unavailable

    • Loading: 140 mg/kg PO
    • Maintenance: 70 mg/kg PO q4h x 17 doses
    • Mix with juice/soda for palatability
    • Repeat dose if vomiting within 1 hour
  14. Path rejoins step 09Shared downstream outcome
  15. Path rejoins step 12Shared downstream outcome
  16. 14Action

    Repeated Supratherapeutic

    RSTI - nomogram not applicable

    • Total dose >4g/day (or >75 mg/kg/day)
    • Treat if: APAP detectable AND AST/ALT elevated
    • Or: Total dose >10g in 24h regardless of labs
  17. Path rejoins step 06Shared downstream outcome

Guideline Source

JAMA Network Open Consensus Statement on Acetaminophen Poisoning 2023

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Rumack-Matthew nomogram only for single acute ingestion
  • Extended-release and repeated supratherapeutic ingestions need modification
  • NAC dosing protocols may vary by institution
  • Liver transplant criteria require specialist input

Applicable Regions

USEUGlobal

US: JAMA 2023 consensus current

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the Acetaminophen Toxicity Management (JAMA 2023)?

The Acetaminophen Toxicity Management (JAMA 2023) is a emergency clinical algorithm for Emergency Medicine. It provides a structured decision tree to guide clinical decision-making, based on JAMA Network Open Consensus Statement on Acetaminophen Poisoning 2023.

What guideline is the Acetaminophen Toxicity Management (JAMA 2023) based on?

This algorithm is based on JAMA Network Open Consensus Statement on Acetaminophen Poisoning 2023 (DOI: 10.1001/jamanetworkopen.2023.24092).

What are the limitations of the Acetaminophen Toxicity Management (JAMA 2023)?

Known limitations include: Rumack-Matthew nomogram only for single acute ingestion; Extended-release and repeated supratherapeutic ingestions need modification; NAC dosing protocols may vary by institution; Liver transplant criteria require specialist input. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acetaminophen Toxicity Management (JAMA 2023) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free